We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

DeNovix Receives Patent for Innovations In Microvolume UV-Vis

DeNovix Receives Patent for Innovations In Microvolume UV-Vis

DeNovix Receives Patent for Innovations In Microvolume UV-Vis

DeNovix Receives Patent for Innovations In Microvolume UV-Vis

Read time:

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "DeNovix Receives Patent for Innovations In Microvolume UV-Vis"

First Name*
Last Name*
Email Address*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy


DeNovix has announced the granting of US patent 9,442,009 associated with instrumentation to improve the accuracy and reliability of microvolume spectrophotometry. 

The patent, “Apparatus and Method for Making Optical Measurements of Samples” recognizes and protects DeNovix’ novel opto-mechanical design. The patented design, combined with proprietary measurement algorithms developed by DeNovix application scientists and engineers, delivers greatly improved accuracy of pathlength determination and increased sensitivity over existing techniques. 

“The innovations in this patent are some of the key advances that make our DS-11 Series the most sensitive and reliable microvolume UV-Vis spectrophotometer available,” said Fred Kielhorn, CEO of DeNovix. “We are delighted that the USPTO has recognized the novelty of our design and the work of our team.” 

“The ability to set measurement pathlengths with such precise control and long-term reproducibility is one of the core innovations that DeNovix has brought to the market. We reinvented the microvolume measurement process to deliver a system that is calibration-free and delivers industry-leading lower and upper detection limits. The dynamic range is truly best-in-class,” stated Kielhorn.

The DeNovix DS-11 FX+ combines patented and patent pending absorbance and fluorescence technologies to deliver the most flexible and complete system available for nucleic acid and protein quantification. DeNovix SmartPath® Technology enables rapid and accurate 1 µL UV-Vis quantification over an industry-leading dynamic range of 0.75 ng/µL dsDNA to 37500 ng/µL. The addition of fluorescence also enables researchers to measure picogram concentrations of sample with increased specificity in one compact instrument. 

The DS-11 FX Series features full Wi-Fi, USB, and Ethernet connectivity allowing users to easily export data via email, a USB drive, to network drives or network printers, or print cryotube labels with an optional printer. Measurements are made using DeNovix’ highly rated, custom Android™ operating system and a stunning, high-resolution, glove-compatible touch screen. Intuitive EasyApps® software featuring pre-configured and custom applications make the DS-11 Series easy to use as well as powerful and flexible.